AT
Aer Therapeutics, Inc.
SEC filingBiotechnology · Research Triangle Park, NC
Amount raised$3Msold at filing
Total offering$3M
Investors in the raise7count reported to the SEC
FiledAug 19, 2026first sale Aug 7, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Evan CaplanDirector
Tim ShannonDirector
John FahyDirector
Thomas MathersExecutive Officer, Director
Christy ShafferDirector
Executive officers, directors and promoters as listed on the Form D.